10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,292 | 180 | -34,358 | -182,627 | -133,599 |
| Depreciation Amortization | 32,530 | 19,465 | 9,814 | 43,708 | 35,598 |
| Accounts receivable | 44,546 | 37,917 | 35,325 | 26,951 | 31,321 |
| Accounts payable and accrued liabilities | 3,292 | 3,488 | -2,547 | -3,354 | 10,044 |
| Other Working Capital | 6,361 | -25,409 | 28,280 | 2,338 | 2,630 |
| Other Operating Activity | 35,836 | 16,418 | -2,163 | 119,648 | 67,418 |
| Operating Cash Flow | $95,273 | $52,059 | $34,351 | $6,664 | $13,412 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,141 | 639 | N/A | -19,238 | 29,638 |
| PPE Investments | -4,158 | -3,471 | -1,893 | -12,393 | -9,677 |
| Net Acquisitions | -8,616 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,000 | -1,000 |
| Other Investing Activity | 0 | 0 | 0 | -1,000 | -1,000 |
| Investing Cash Flow | $-11,633 | $-2,832 | $-1,893 | $-32,631 | $18,961 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,561 | 3,944 | 422 | 10,914 | 6,397 |
| Financing Cash Flow | $4,561 | $3,944 | $422 | $10,914 | $6,397 |
| Exchange Rate Effect | 441 | 474 | 114 | -164 | 105 |
| Beginning Cash Position | 344,067 | 344,067 | 344,067 | 359,284 | 359,284 |
| End Cash Position | 432,709 | 397,712 | 377,061 | 344,067 | 398,159 |
| Net Cash Flow | $88,642 | $53,645 | $32,994 | $-15,217 | $38,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | 95,273 | 52,059 | 34,351 | 6,664 | 13,412 |
| Capital Expenditure | -4,158 | -3,471 | -1,893 | -12,393 | -9,677 |
| Free Cash Flow | 91,115 | 48,588 | 32,458 | -5,729 | 3,735 |